SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-20-000056
Filing Date
2020-11-06
Accepted
2020-11-06 16:11:28
Documents
91
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20200930x10q.htm   iXBRL 10-Q 3055123
2 EX-10.1 amph-20200930ex1013f0b05.htm EX-10.1 814440
3 EX-31.1 amph-20200930ex311813f4a.htm EX-31.1 18831
4 EX-31.2 amph-20200930ex3126792d1.htm EX-31.2 18486
5 EX-32.1 amph-20200930ex3218ae9ba.htm EX-32.1 9574
6 EX-32.2 amph-20200930ex32281145c.htm EX-32.2 9575
  Complete submission text file 0001297184-20-000056.txt   12378592

Data Files

Seq Description Document Type Size
7 EX-101.SCH amph-20200930.xsd EX-101.SCH 64651
8 EX-101.CAL amph-20200930_cal.xml EX-101.CAL 65014
9 EX-101.DEF amph-20200930_def.xml EX-101.DEF 229185
10 EX-101.LAB amph-20200930_lab.xml EX-101.LAB 489015
11 EX-101.PRE amph-20200930_pre.xml EX-101.PRE 440122
12 EXTRACTED XBRL INSTANCE DOCUMENT amph-20200930x10q_htm.xml XML 2501626
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 201294529
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences